№ files_lp_4_process_3_107436
File format: docx
Character count: 22063
File size: 89 KB
Clinical source detailing the responsibilities, relationships, and operational scope of a specialist pharmacist in gastroenterology, including inpatient, outpatient, and homecare services.
Job Title:
Specialist Pharmacist – Gastroenterology and Inflammatory Bowel Disease (Northern Services)
Reports to:
Clinical Pharmacy Manager
Band:
Band 8a
Department/Directorate:
Pharmacy / Specialist Services
Organisation:
Royal Devon University Healthcare NHS Foundation Trust
Location:
Northern Services, United Kingdom
Role Type:
Clinical Specialist
Responsibilities:
Leading clinical pharmacy service, independent prescribing, medicines management, patient care, high-cost drug monitoring
Key Relationships:
Gastroenterology clinical team, pharmacy staff, external healthcare partners, NHS England, GP practices, community pharmacies
Patient Interaction:
Inpatients, outpatients, homecare patients
Education/Training:
Participation in education programmes for staff, patients and carers
Compliance:
National guidelines, legislation, Trust policies
Work Schedule:
Flexible, includes weekends and late bank holidays
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2017
Region / City:
Blackpool
Topic:
Gastroenterology, Endoscopy Services
Document Type:
Policy
Organization:
Blackpool Teaching Hospitals NHS Foundation Trust
Author:
XX Gastro Unit Nurse Manager
Target Audience:
Trust Wide
Period of Action:
07/09/2017 to 01/05/2020
Approval Date:
07/09/2017
Review Date:
01/05/2020
Note:
Year
Year:
2012
Region / City:
Europe
Topic:
Medical Training
Document Type:
Educational Standards
Institution:
European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Author:
Education Committee of ESPGHAN
Target Audience:
Medical professionals in the field of Paediatric Gastroenterology, Hepatology and Nutrition
Period of Application:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
Not specified
Region / Country:
Australia; Aotearoa New Zealand
Specialty:
Gastroenterology (Adult Medicine and Paediatrics & Child Health)
Document type:
Training rotation progress report form
Institution:
Royal Australasian College of Physicians (RACP)
Training program:
Advanced Training in Gastroenterology
Purpose:
Assessment of trainee progress during a training rotation under the new curriculum
Target audience:
Trainees and Rotation Supervisors
Assessment domains:
Professional behaviours; Entrustable Professional Activities; Knowledge guides
Submission method:
Email submission pending availability via Training Management Platform (TMP)
Related platform:
Training Management Platform (TMP)
Associated policies:
RACP Education policies
Completion requirements:
Trainee self-assessment; Supervisor review; Progression recommendation; Optional additional supervisor assessment; Optional trainee reflection
Journal:
Minerva Gastroenterology
Publisher:
Edizioni Minerva Medica S.p.A.
Document Type:
Submission Statement
Field:
Gastroenterology
Subject:
Manuscript submission declarations and warranties
Parties Involved:
Authors; Corresponding Author; Publisher
Referenced Organization:
International Committee of Medical Journal Editors (ICMJE)
Ethical Framework:
Helsinki Declaration (2024 revision)
Scope:
Original research manuscripts including studies involving human subjects, human embryos, gametes, embryonic stem cells, and animals
Key Sections:
Manuscript Data; Definitions; Declarations; Representations and Warranties
Obligations:
Authorship criteria compliance; originality and non-duplication; ethical approval; conflict of interest disclosure; data availability statement; publication charges responsibility
Organization:
U.S. News & World Report
Collaborating organization:
RTI International
Document type:
Survey questionnaire section
Medical specialty:
Pediatric Gastroenterology
Sector:
Healthcare / Hospital administration
Geographic scope:
United States
Target respondents:
Hospitals with Pediatric Gastroenterology programs
Purpose:
Collection of program structure, staffing, services, and patient volume data for specialty evaluation
Data categories:
Clinical staff numbers, program contacts, outpatient visit volume, clinical services, technologies, interdisciplinary programs
Referenced professional bodies:
American Board of Pediatrics; American Board of Surgery
Reporting unit:
Hospital Pediatric Gastroenterology program
Submission notes:
Joint reporting between hospitals requires prior approval
Contact email mentioned:
[email protected]
Year:
2017
Region / city:
United Kingdom
Subject:
Faecal microbiota transplant (FMT) for Clostridium difficile infection and other indications
Document type:
Clinical guidelines
Organization / institution:
British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS)
Authors:
Working group of BSG and HIS
Target audience:
Healthcare professionals, clinicians
Period of validity:
Ongoing (as of publication)
Approval date:
Not specified
Date of revisions:
Not specified
Scope:
Guidelines for the use of faecal microbiota transplant in treating Clostridium difficile infection (CDI) and other clinical conditions
Clinical management:
Recommendations for patient selection, donor selection, and FMT administration
Economic aspects:
Cost-effectiveness of FMT compared to traditional therapies for CDI
Year:
2021
Region / City:
Pirassununga, SP, Brazil
Topic:
Veterinary medicine, animal welfare, swine castration
Document Type:
Research article
Institution:
University of Sao Paulo, North Carolina State University, Washington State University, Michigan State University, Iowa State University, University of Missouri
Author:
Laya Kannan Silva Alves, Monique Danielle Pairis-Garcia, Juliana Bonin Ferreira, Victoria Rocha Merenda, Rubia Mitalli Tomacheski, Pedro Henrique Esteves Trindade, Christopher Siepker, Magdiel Lopez-Soriano
Target Audience:
Researchers, veterinary professionals
Period of Study:
Not specified
Approval Date:
Not specified
Date of Revision:
Not specified
Year:
2019
Region / City:
Naas General Hospital
Topic:
Inflammatory Bowel Disease, Biologic Medication
Document Type:
Policy
Author:
Joanna Rea, Inflammatory Bowel Disease Clinical Nurse Specialist
Target Audience:
IBD CNSp, Gastroenterology team, nursing staff administering biologic medication
Approval Date:
14th January 2020
Revision Date:
January 2023
Version Number:
1
Supporting Evidence:
Infliximab, Remicade, Vedolizumab, Adalimumab, Imraldi, Amgevita, Hulio, Golimumab, Ustekinumab
Purpose:
Standardization of pre-screening and management of IBD patients requiring biologic treatment
Scope:
Biologic screening, patient education, IBD CNSp, gastroenterology team, nursing staff
Objective(s):
Ensure best practice for IBD patients on biologics
Outcome(s):
Clarity for staff on safe and evidence-based care for IBD patients on biologics
Governance:
IBD Working Group
Review Group:
Not Applicable
Date of Approval:
14th January 2020
Date of Next Revision:
January 2023
Year:
2015
Region / City:
Zurich, Switzerland
Topic:
Inflammatory bowel disease
Document type:
Journal Article
Organization / Institution:
University Hospital Zurich, University of California Riverside
Author:
Marianne R Spalinger, Declan F McCole, Gerhard Rogler, Michael Scharl
Target audience:
Researchers, medical professionals
Period of validity:
N/A
Approval date:
N/A
Modification date:
N/A
Year:
2010
Region / City:
Global
Document Type:
Medical Research Article
Organization / Institution:
Various Medical Institutions and Study Groups
Author:
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, et al.
Target Audience:
Healthcare professionals, researchers
Period of Action:
2006-2012
Approval Date:
April 15, 2010
Modification Date:
N/A
Note:
Year
Region / City:
Shanghai, China
Topic:
Tumor Immunology, Hepatocarcinogenesis
Document Type:
Research Supplementary Material
Institution:
Third Affiliated Hospital of Second Military Medical University, National Center for Liver Cancer
Author:
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei
Target Audience:
Researchers in Tumor Immunology, Oncology
Context:
A research document providing detailed methods and experimental procedures on hepatocarcinogenesis and tumor immunology based on single-cell analysis and cell culture experiments.
Year:
2025
Month of Revision:
February 2025
Country:
United Kingdom
Healthcare System:
NHS
Service:
Rheumatology Early Inflammatory Arthritis (EIA) Service
Type of Document:
Medical referral form
Target Group:
Patients aged 18 years or above
Referral Priority:
Urgent (3 week wait)
Required Referral Method:
e-RS
Clinical Criteria:
Persistent joint inflammation ≥ 6 weeks in 2 or more joints with specified clinical features
Required Investigations:
FBC, E&C, LFT, ESR, CRP, RhF, ANA, Anti-CCP, X-rays hands/feet if symptomatic
Treatment Pathway Reference:
DMARD therapy within 6 weeks if diagnosis confirmed
Follow-up Sites:
WRH, KTC, ALX
Title of study:
Addressing unmet needs in adult inflammatory bowel disease care
Type of document:
Participant Information Sheet
Study type:
Online survey as part of a Doctor of Philosophy (PhD) Degree
Researcher:
Charlotte Playford
Supervisors:
Stephanie Armstrong; Zahid Asghar; Richard Ngomba; Andrew Rochford
Institution:
University of Lincoln
Collaborating organisation:
National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) East Midlands
Country:
United Kingdom
Target participants:
Healthcare clinicians working within an IBD service in the United Kingdom
Sample size:
Approximately 10 participants
Data collection method:
Online survey and optional follow-up semi-structured interview
Data storage:
University OneDrive and secure university premises
Ethical approval reference:
2024_17184
Funder:
University of Lincoln; NIHR Applied Research Collaboration (ARC) East Midlands
Purpose:
Exploration of clinician perspectives on unmet needs and multidisciplinary care in adult IBD management
Confidentiality:
Anonymous data collection with optional identifiable follow-up consent
Withdrawal policy:
Withdrawal permitted before survey submission
Year:
2024
Region / City:
Rize, Türkiye
Topic:
Geriatric sarcopenia and inflammation
Document Type:
Research article
Institution:
Recep Tayyip Erdoğan University Faculty of Medicine
Authors:
Handan Duman, Damla Tüfekçi
Target Population:
Adults aged ≥80 years
Study Design:
Cross-sectional observational study
Ethics Approval:
Recep Tayyip Erdoğan University Clinical Research Ethics Committee, decision no. 2024/175
Corresponding Author:
Handan Duman, Department of Family Medicine, Recep Tayyip Erdoğan University
Keywords:
Sarcopenia, systemic immune-inflammation index (SII), C-reactive protein/albumin ratio (CAR), very old adults
Methods:
SARC-F questionnaire, handgrip dynamometry, calculation of SII and CAR
Exclusion Criteria:
Age <80 years, active malignancy, acute infection, immunodeficiency, advanced chronic kidney failure, cerebrovascular events, end-stage heart failure, trauma, psychiatric disorders
Running title:
Biomarker ratios for personalized therapeutic decisions
Authors:
Dejana Bajić; Nemanja Todorović; Mladena Lalić Popović; Ljiljana Andrijević
Affiliation:
Department of Biochemistry, Faculty of Medicine, University of Novi Sad; Department of Pharmacy, Faculty of Medicine, University of Novi Sad
Institution:
Institute for Pulmonary Diseases of Vojvodina, Clinic for Intensive Medicine and Vascular Pulmonary Diseases, Department for Intensive Care and Intoxications Level 3
Country:
Serbia
Corresponding author:
Dejana Bajić, MD, PhD
ORCID IDs:
0000-0002-7958-068X; 0000-0002-1519-5643; 0000-0001-8354-3868; 0000-003-0676-7985
Study design:
Retrospective observational clinical study
Study period:
November 2020 – February 2022
Sample size:
133 ICU patients with COVID-19-related sepsis
Primary endpoint:
28-day mortality
Biomarkers analyzed:
Neutrophil-to-lymphocyte ratio (NLR); Fibrinogen-to-albumin ratio (FAR); C-reactive protein-to-albumin ratio (CAR)
Statistical methods:
ROC curve analysis; logistic regression
Ethical approval:
Ethics Committee of the Institute for Pulmonary Diseases of Vojvodina (Protocol Code No. 9-II/3, February 24, 2022); Ethics Committee of the Faculty of Medicine, University of Novi Sad (Protocol Code No. 01-39/190/1)
Conflicts of interest:
None declared
Funding:
No financial support received
Keywords:
biomarkers; COVID-19; inflammation; prognosis
Year:
2023
Region / City:
Not specified
Subject:
Radiology, Musculoskeletal Imaging
Document Type:
Audit Report
Organization / Committee:
ESSR Arthritis Subcommittee, Royal College of Radiologists
Authors:
Dr KS Yung, Dr HM Kwok, Dr NY Pan
Target Audience:
Radiologists, Sonographers, Rheumatologists
Effective Period:
Six months prior to audit or most recent 50 cases
Approval Date:
11 August 2023
Last Reviewed:
1 August 2023
References:
Diekhoff T, Lambert R, Hermann KG (2022); Sudoł-Szopińska I, Jurik AG, Eshed I, et al. (2015); Lambert RG, Bakker PA, van der Heijde D, et al. (2016); Tsoi C, Griffith JF, Lee RKL, Wong PCH, Tam LS (2019); Mandl P, Navarro-Compán V, Terslev L, et al. (2015)
Standards:
MRI sequences for suspected inflammatory sacroiliitis should include coronal oblique T1-weighted and STIR/TIRM, with reporting of active and structural changes, lesion site, number, and location
Year:
2021
Region / City:
Shanghai, China
Topic:
Inflammatory myofibroblastic tumor, Metformin treatment
Document type:
Case report
Organization / Institution:
Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine
Author(s):
Yu Liang, Hong-Xiang Gao, Rui-Cheng Tian, Jing Wang, Yu-Hua Shan, Lei Zhang, Chen-Jie Xie, Jing-Jing Li, Min Xu, Song Gu
Target audience:
Medical professionals, researchers in oncology and pediatrics
Period of validity:
Not applicable
Approval date:
January 16, 2021
Modification date:
Not applicable
Year:
Not specified
Region / city:
Not specified
Topic:
Tumor immunology, treatment methods
Document type:
Scientific article
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, Immunologists
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2026
Region/Location:
Not specified
Subject:
Melanoma research
Document type:
Supplementary data tables
Institution:
Research laboratory / academic study
Author:
Not specified
Sample size:
NEVI (14), Primary Malignant Melanoma (23), Metastatic Melanoma (15)
Methods:
Immunohistochemistry for PD-L1, BRAF codon 600 genotyping, inflammatory scoring
Cell lines:
Human melanoma cultured cells
Treatment:
IFN-gamma induction
Data metrics:
%PD-L1 expression, inflammation score, ∆MFI for PD-L1 and MHC I
Context:
Archival melanoma tissue samples and cultured melanoma cell lines analyzed for PD-L1 expression, BRAF mutation status, and immune response markers in experimental study